Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Tfc 1067?
View:
Post by SleepyHoward on Sep 27, 2023 7:09am

Tfc 1067?

https://www.dovepress.com/getfile.php?fileID=93085
Comment by tylerreddick on Sep 27, 2023 7:44am
Has to be, unless they were testing another revolutionary dark spot treatment at the same time they were doing ours. Surely, surely, this will convince Allergen to get off their rears and get an actual product on the market, hopefully before we go belly up.
Comment by Turtle4 on Sep 27, 2023 9:45am
They do need an internal alternative to the TFC1067 product. Because Howie insisted on a high royality, the margin for allergan is naturally worse than for its own active ingredient. Then they would rather push SPOT TX
Comment by tylerreddick on Sep 27, 2023 10:14am
What makes you think Spot TX doesn't contain TFC1067?
Comment by Turtle4 on Sep 27, 2023 11:41am
No Difluorocyclohexyloxyphenol in the ingredients list.
Comment by tylerreddick on Sep 27, 2023 12:38pm
Where did you find the ingredients list? TIA
Comment by Porcupine9 on Sep 27, 2023 1:47pm
Try to keep up, Joey!
Comment by lscfa on Sep 27, 2023 1:10pm
Same article published March 2023, so why now again? https://jofskin.org/index.php/skin/article/view/1993
Comment by lscfa on Sep 27, 2023 1:17pm
Also, study was presented October 2022... https://news.abbvie.com/news/press-releases/allergan-aesthetics-to-present-data-from-its-leading-aesthetic-portfolio-at-2022-american-society-for-dermatologic-surgery-meeting.htm
Comment by biorun on Sep 27, 2023 4:16pm
They publish and circulate to support future marketing and engagement efforts with their knowledgeable client/supplier base..all major leading manufacturers do this - keeps people paying attention and eager for the next big thing. While it is positioning it as a premier solution, it doesn't mean it will be launched any time soon - that deep dark secret appears to be locked in the vault over ...more  
Comment by Pareto8020 on Sep 27, 2023 4:30pm
Considering they've had the results and a deal in place since June 2022 they definitely seem to be taking their sweet time in getting it onto shelves.  Howie probably never negotiated any kind of time requirements so lord knows when they will bring it to market. No news, staff being let go, no income, no updates....so everything is status quo at Sirona.  This is not how to run a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities